Position in OGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$50,599,467
+$7,113,685 QoQ
Shares Held
3,737,036
-48.5% QoQ
Ownership
1.42%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#13
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $2,451,058,699 across 9 Drug Manufacturers - General names. OGN ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
5,299,408 | $680,973,928 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
9,852,232 | $567,685,607 | |
| 3 | PFE |
Pfizer Inc
|
18,940,504 | $456,087,336 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,635,721 | $332,996,991 | |
| 5 | AMGN |
Amgen Inc
|
603,549 | $218,557,163 | |
| 6 | BIIB |
Biogen Inc.
|
444,049 | $95,941,226 | |
| 7 | OGN |
Organon & Co.
This page
|
3,737,036 | $50,599,467 | |
| 8 | JNJ |
Johnson & Johnson
|
184,693 | $46,906,481 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,599,467 | 3,737,036 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $43,485,782 | 7,259,730 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $53,577,315 | 7,472,429 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $83,672,887 | 7,834,540 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $77,337,972 | 7,989,460 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $118,833,739 | 7,980,775 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $112,274,133 | 7,525,076 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $143,370,148 | 7,494,519 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $136,842,897 | 6,610,768 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $84,389,966 | 4,488,828 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $48,300,929 | 3,349,579 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $52,632,950 | 3,031,852 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $57,861,206 | 2,780,452 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $63,684,610 | 2,707,679 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $71,101,931 | 2,545,719 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $59,474,212 | 2,541,633 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $62,793,562 | 1,860,550 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $41,992,811 | 1,202,199 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $33,250,943 | 1,091,985 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $32,616,704 | 994,715 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $31,558,668 | 1,042,917 | Shares | Sole | 2021-08-04 | |
| No filing history on record for this holder in this stock. | ||||||